MapLight Therapeutics' Vishwas Setia Separated As CFO Effective Immediately; Jonathan Gillis Appointed As Interim CFO Effective June 18, 2026

뉴스 본문을 불러오고 있어요.

MapLight Therapeutics' Vishwas Setia Separated As CFO Effective Immediately; Jonathan Gillis Appointed As Interim CFO Effective June 18, 2026 | 웨이프 WAPE

MapLight Therapeutics' Vishwas Setia Separated As CFO Effective Immediately; Jonathan Gillis Appointed As Interim CFO Effective June 18, 2026

기사 요약

관련 종목

댓글 —